COVIDIEN MFG SOLUTIONS S.A. MAHURKAR; CATHETER, INTRAVASCULAR, THERAPEUTIC, SHORT-TERM LESS THAN 30 DAYS
|
Back to Search Results |
|
Model Number 8831661001 |
Device Problems
Difficult to Remove (1528); Unraveled Material (1664)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 04/13/2022 |
Event Type
malfunction
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
According to the reporter, during catheter placement, while inserting the guide wire (included in the catheter kit) into the patient, it was found to be in a stretched state, and so it was not continued to be used.There was no leak and no luer adapter issue.There was nothing unusual observed on the device prior to use, flushing was done prior to use, guidewire had no problem, and there were no other defects/damages found in the product.The insertion site was treated with an ordinary disinfection treatment prior to product placement, there were no other products utilized with the device, no excessive force was used on the device, the cleaning agent used on the device was iodophor, tego was not utilized, and the catheter was not repaired.It was stated that the guidewire was removed by hand and it was necessary to remove the guide wire and catheter from the patient simultaneously (in one action) due to the alleged defect.The guidewire was in an uncoiled state when removed and it did not break into fragments (all components were still on one guide wire and not dropped).All pieces were accounted for, and x-ray was not required to check if all pieces were accounted for.The product was replaced, and the surgery was completed.There was no intervention/treatment required as a result of the event.There were no patient symptoms or complications associated with this event.The event did not result to any vessel damage.There was no blood loss and blood transfusion was not required due to the event.There was no reported patient injury.
|
|
Manufacturer Narrative
|
Additional information: removed a3, d9, g1, g3, h3, h6 h3 evaluation summary: medtronic conducted an investigation based upon all information received.The device was available for evaluation.Visual inspection noted the guidewire was stretched and deformed.It was reported that the guide wire was unable to be withdrawn and was frayed, coiled or unraveled.The reported issues were confirmed.The most likely cause could not be established from the information available.The manufacturing records for each device are thoroughly reviewed prior to release to ensure that it meets all medtronic quality specifications.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|